Jiayun Lu

11PUBLICATIONS
152CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 30, 2026
Immunometabolic effects of oral testosterone for castration-resistant prostate cancer in the ACROBAT trial.

|Aug 14, 2026
Clinical, Genomic, and Spatial Transcriptomic Features of Pancreatic Adenosquamous Carcinoma Support Subtype-Specific Therapeutic Strategies.

|Jul 16, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

|Jun 30, 2026
A Randomized Phase II Study of Combination Atezolizumab and Varlilumab (CDX-1127) with or without Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer.

|May 01, 2026
HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer.

|May 19, 2025
Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Eric S Christenson, Won Jin Ho, Daniel Shu

Pageof 2

Frequent Collaborators

5 joint publications

Hao Wang

5 joint publications

Corrine E Joshu

4 joint publications

Elizabeth A Platz

4 joint publications

Nilofer Saba Azad